Week in review: Myopia microdose, virtual surgery, happy okapi

This week, a micro-therapeutic formulation of atropine enters phase 3 trials, Genentech uses virtual reality to train retinal surgeons and an endangered okapi calf undergoes surgery to remove a corneal lesion.
Source: AAO

Posted in: Uncategorized

Leave a response

658 Malta Ave, Suite 101 Malta, NY 12020 (518) 580-0553